Pharmacological perspective to mitigate the COVID-19 management in the Alzheimer’s Disease and Related Dementia: An update

Pharmacological perspective to mitigate the COVID-19 management in the Alzheimer’s Disease and Related Dementia: An update

Registration ID: IJNRD_180558

Published ID: IJNRD2203002

DOI: Click Here to Get

Subhasish Sahoo , Diptirani Rath

COVID-19, Alzheimer’s disease, Cognitive impairment, pulmonary diseases, risk factors, Geriatric vaccination.

Background COVID-19 was found in late 2019 which causes severe respiratory illness. Cognitive impairment patients who are suffering from Alzheimer’s Disease and Related Dementias (ADRD) are having a higher risk of COVID infection and other pulmonary diseases leading to a high mortality rate. A risk factor is the ‘age’ that forms a link between Alzheimer’s and the morbidity related to COVID 19. This perspective encloses the measures which may help to mitigate the management of COVID-19 in Alzheimer’s Disease and Related Dementias (ADRD). The article updates primarily on prevalence, incidence, associated risk factors, supervision, and care for patients suffering from ADRD which can help to decrease the burden on the patients suffering from ADRD. Methods This article was reviewed referring to websites like Scopus, Google Scholar, ScienceDirect, PubMed, MedKnow Publications, NCBI.NLM.NIH, EBSCO, Web of Science, etc. Results and Discussion It was illustrated by various cases of COVID 19 that people with elderly i.e., above 70 years were at high risk of mortality due to weaker immune system, synaptic loss, and impaired cognition. Mortality due to pneumonia is twice more prevalent in dementia patients than in the without dementia. Smoking is another risk factor for AD in elderly persons. According to the previous cases reported, it was found that people who were taking high consumption of fish, omega-3-polyunsaturated fatty acid diet linked to lessen the chances of AD and dementia-like symptoms. Patients with AD and related dementia should be encouraged for virtual meeting/ e-consultation/ telemedicine/ online mental health programs instead of clinical visits. Vaccination would greatly assist geriatric people during the COVID-19 pandemic which may help them to overcome the infection.

Published Paper   E-Certificate

"Pharmacological perspective to mitigate the COVID-19 management in the Alzheimer’s Disease and Related Dementia: An update", IJNRD - INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (www.IJNRD.org), ISSN:2456-4184, Vol.7, Issue 3, page no.27-31, March-2022, Available :https://ijnrd.org/papers/IJNRD2203002.pdf

Volume 7 Issue 3, March-2022

Pages : 27-31

Paper Reg. ID: IJNRD_180558

Published Paper Id: IJNRD2203002

Downloads: 000121147

Research Area: Pharmacy

Country: Bhubaneswar, Odisha, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2203002.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2203002

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 8 | August 2025

IJNRD is Scholarly open access journals, Peer-reviewed, and Refereed Journals, High Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool), Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) with Open-Access Publications.

INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to explore advances in research pertaining to applied, theoretical and experimental Technological studies. The goal is to promote scientific information interchange between researchers, developers, engineers, students, and practitioners working in and around the world. IJNRD will provide an opportunity for practitioners and educators of engineering field to exchange research evidence, models of best practice and innovative ideas.

Indexing In Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar | AI-Powered Research Tool, Microsoft Academic, Academia.edu, arXiv.org, Research Gate, CiteSeerX, ResearcherID Thomson Reuters, Mendeley : reference manager, DocStoc, ISSUU, Scribd, and many more

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: August 2025

Current Issue: Volume 10 | Issue 8

Last Date for Paper Submission: Till 31-Aug-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: International Peer-reviewed, Refereed, and Open Access Journal.

Subject Category: Research Area